RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
RT @Cardio_delaGuia: Anticoagulación (AC) y Supervivencia Hospitalaria #COVID19 @JACCJournals ▪️ El 28% recibieron AC sistémica ▪️ Los que…
Anticoagulación (AC) y Supervivencia Hospitalaria #COVID19 @JACCJournals ▪️ El 28% recibieron AC sistémica ▪️ Los que recibieron AC: más probabilidades requerir ventilación ▪️ Cuánto más tiempo AC, < riesgo de mortalidad ▪️ Hemorragias >> en ptes
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
RT @schneiderleonid: Folks, it #heparin now. Brace yourselves for a new wild ride.
RT @TimSweeney83: #COVID19 pts on the vent who were treated with anticoagulation had improved outcomes in observational study. But AC carri…
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
RT @Aiims1742: Vis-a-vis the thrombotic events observed in #COVID19 (See autopsy findings below), this large retrospective analysis by @gir…
RT @iamritu: @adamcifu It’s all in the narrative, Adam @adamcifu @djc795 https://t.co/N34DzpzH14 https://t.co/pgcxltmOBT
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
RT @1kylejam: https://t.co/cO9dOIzJV5. Longer duration of anticoagulation showed reduced mortality in COVID. Limited study as they did not…
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
RT @hrkz1985: 人工呼吸器を必要としている重症COVID-19患者に対する抗凝固療法は予後を改善するかもしれない。観察研究。 https://t.co/BXSmAoTlfP
No me queda muy claro el tipo y la dosis de anticoagulantes que recibieron los pacientes. Association of Treatment Dose Anticoagulation with In-Hospital Surviva... https://t.co/uuBRIAhnAG
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
Systemic anticoagulation in #COVID19 hospitalized patients may be associated with improved survival in both ventilated and non-vented patients. Observational data, RTC needed. @NidaQadirMD @drtishawang @boback @gcfmd @rgbMDPhD
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 Ishan Paranjpe, Valentin Fuster et al. https://t.co/yuKaxBRrj7
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 Ishan Paranjpe, Valentin Fuster et al. https://t.co/brmaQH1CV3
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
Good old heparin better than Remdesivir? #COVID19 Association of Treatment Dose Anticoagulation with In-Hospital Surviva... https://t.co/BkHc0kvcWc
Important interpretation here.
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
@adamcifu It’s all in the narrative, Adam @adamcifu @djc795 https://t.co/N34DzpzH14
RT @schneiderleonid: Folks, it #heparin now. Brace yourselves for a new wild ride. https://t.co/HfTfGQF1tT
RT @TKFM_Sakamoto: COVID19入院中の抗凝固療法の有無と生存率の関係。 人工呼吸器管理が必要な症例では抗凝固療法施行を行っていた方が生存率が良かったとのこと。 COVID19の病態の一つとしての血栓症の関与と治療法としての選択肢は外堀が埋められてきた印象。
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
Treatment with anticoagulants, such as the #glycan #heparin, in hospitals is associated with increased survival in severe #COVID19 patients and especially those on ventilation. https://t.co/YARfeT3XJt
Does this paper answer the question of FULL DOSE anticoagulation in #COVID19? I don't think so @JACCJournals... e.g. limitations - Indication for AC and VTE status not known. Also, bleeding rate feels low https://t.co/laHu2HrHhw @bhwords @ProfMakris @m
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
RT @aakonc: A more detailed look at this @JACCJournals #COVID19 anticoagulant study, linked here: https://t.co/h5ZhWPyv9f Key takeaways: 1…
https://t.co/cO9dOIzJV5. Longer duration of anticoagulation showed reduced mortality in COVID. Limited study as they did not look at indications for AC other than COVID
A more detailed look at this @JACCJournals #COVID19 anticoagulant study, linked here: https://t.co/h5ZhWPyv9f Key takeaways: 1. Retrospective N=2773, no randomization, evaluated THERAPEUTIC dose anticoag (AC, 28% of pop) vs not 2. In-hospital mortality 22
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
Ver artículo en: https://t.co/A2hvbc4MID
RT @dranulala: So. Much. To. Learn. #COVID19 #MountSinaiStrong @MountSinaiHeart @ACCinTouch
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
RT @DavidBarounis: Systemic Anticoagulation has been used in our algorithm for critically ill patients despite recommendations for prophyla…
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
RT @DavidBarounis: Systemic Anticoagulation has been used in our algorithm for critically ill patients despite recommendations for prophyla…
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
RT @Icomem_Oficial: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with #COVID-19 #JAC…
In observational COVID studies, be aware of bias related to differential intensification of care. A 30% vs 8% intubation rate with similar mortality cannot be explained by anticoag, but it can by bias. Anticoagulation and Survival in COVID-19 https://t.c
RT @TaniaAhuja: while we all try to find ways to ⬇️ #thrombosis w/ #COVID19, findings like this add to 🤯 bc of confounders 🤔 how did AC for…
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 https://t.co/xcgVybFrFf
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
I understand the numbers here are impressive, but it’s just an association. This is being covered in the press like we discovered a new treatment. @JACCJournals can do better. Need RCTs!!! https://t.co/vQgA4N8r0K
Cada vez mas fuerte la idea de anticoagular a ptes de riesgo #COVID19 estamos esperando en ptes de algo riesgo un randomizado que v a llegar demasiado tarde? Otra vez @IndigospiritMSH @MtSinaiQueens liderando con Dr Fuster a la cabeza https://t.co/uH0zOiqG
RT @iamritu: Observational study of n=786 w possible unobserved confounding, unknown indication for AC, lack of metrics to further classify…
RT @Noboru_Hagino: この論文に加えて、僕は、今のところ抗凝固は「DOACを使わない方がよい」、もっと積極的に「初期の抗凝固はunfractionated heparinがよい」と推測しています。
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
RT @TKFM_Sakamoto: COVID19入院中の抗凝固療法の有無と生存率の関係。 人工呼吸器管理が必要な症例では抗凝固療法施行を行っていた方が生存率が良かったとのこと。 COVID19の病態の一つとしての血栓症の関与と治療法としての選択肢は外堀が埋められてきた印象。
while we all try to find ways to ⬇️ #thrombosis w/ #COVID19, findings like this add to 🤯 bc of confounders 🤔 how did AC for 3 d ⬇️ 💀from 14 to 21 d? 💉 AC associated with mech. ventilation or illness severity⁉️ 😒 oral AC included - so had reason to be on AC
RT @Aiims1742: Vis-a-vis the thrombotic events observed in #COVID19 (See autopsy findings below), this large retrospective analysis by @gir…
RT @eduolpe: Un estudio observacional con 2.773 pacientes, liderado por el Dr. Fuster @CNIC_CARDIO @MountSinaiNYC, muestra que el tratamien…
人工呼吸器を必要としている重症COVID-19患者に対する抗凝固療法は予後を改善するかもしれない。観察研究。 https://t.co/BXSmAoTlfP
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
AC is just a surrogate for ICU diagnosis: AC = PE better prognosis than ARDS related to Covid19. Not clear if AC = prophylaxis also?
RT @Icomem_Oficial: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with #COVID-19 #JAC…
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
RT @nyheartdoc: “Among patients on mechanical ventilation, in-hospital mortality was 29.1% for those treated with anticoagulants and 62.7%…
RT @Icomem_Oficial: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with #COVID-19 #JAC…
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with #COVID-19 #JACC El virus favorece la aparición de trombosis venosa o arterial, lesión miocárdica, miocarditis y arritmia https://t.co/CJEL6j10c4 #Card
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 | JACC: Journal of the American College of Cardiology https://t.co/16OwBBGPyL
RT @TKFM_Sakamoto: COVID19入院中の抗凝固療法の有無と生存率の関係。 人工呼吸器管理が必要な症例では抗凝固療法施行を行っていた方が生存率が良かったとのこと。 COVID19の病態の一つとしての血栓症の関与と治療法としての選択肢は外堀が埋められてきた印象。…
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 @JACCJournals mentioned @girish_nadkarni this am @HofstraMed rounds https://t.co/UnMD85SJAm
Exciting news about blood thinners for intubated Covid-19 patients
RT @nyheartdoc: “Among patients on mechanical ventilation, in-hospital mortality was 29.1% for those treated with anticoagulants and 62.7%…
RT @TKFM_Sakamoto: COVID19入院中の抗凝固療法の有無と生存率の関係。 人工呼吸器管理が必要な症例では抗凝固療法施行を行っていた方が生存率が良かったとのこと。 COVID19の病態の一つとしての血栓症の関与と治療法としての選択肢は外堀が埋められてきた印象。…
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 https://t.co/wzUycnBAIN
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
RT @Aiims1742: Vis-a-vis the thrombotic events observed in #COVID19 (See autopsy findings below), this large retrospective analysis by @gir…
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 https://t.co/bO5rmYvbgL
RT @DavidBarounis: Systemic Anticoagulation has been used in our algorithm for critically ill patients despite recommendations for prophyla…
RT @TKFM_Sakamoto: COVID19入院中の抗凝固療法の有無と生存率の関係。 人工呼吸器管理が必要な症例では抗凝固療法施行を行っていた方が生存率が良かったとのこと。 COVID19の病態の一つとしての血栓症の関与と治療法としての選択肢は外堀が埋められてきた印象。…
RT @TKFM_Sakamoto: COVID19入院中の抗凝固療法の有無と生存率の関係。 人工呼吸器管理が必要な症例では抗凝固療法施行を行っていた方が生存率が良かったとのこと。 COVID19の病態の一つとしての血栓症の関与と治療法としての選択肢は外堀が埋められてきた印象。…
RT @Aiims1742: Vis-a-vis the thrombotic events observed in #COVID19 (See autopsy findings below), this large retrospective analysis by @gir…
RT @Aiims1742: Vis-a-vis the thrombotic events observed in #COVID19 (See autopsy findings below), this large retrospective analysis by @gir…
RT @eduolpe: Un estudio observacional con 2.773 pacientes, liderado por el Dr. Fuster @CNIC_CARDIO @MountSinaiNYC, muestra que el tratamien…
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
Systemic Anticoagulation has been used in our algorithm for critically ill patients despite recommendations for prophylactic dose LMWH. This is the largest case series to come out so far on outcomes for similar individuals. https://t.co/NrlbQFkCBq
RT @Noboru_Hagino: この論文に加えて、僕は、今のところ抗凝固は「DOACを使わない方がよい」、もっと積極的に「初期の抗凝固はunfractionated heparinがよい」と推測しています。
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…